Skip to content
PodSubs
ShowsPeopleGuestsJobsNewsEvents
More
BlogPodCred
Menu
ShowsPeopleGuestsJobsNewsEventsBlogPodCredNetworksSign in
Join nowSign in
  • Shows
  • People
  • Jobs
  • News
  • More
    • Guests
    • Events
    • Blog
    • PodCred
    • Networks
    Join nowSign in

Beginner's Mind

Beginner's Mind artwork

EP 145: Shlomo Noy - Why Healthcare Innovation Fails Without the Right Strategy

Nov 3, 20242 hr 21 minAudio

Healthcare investment is booming, but why do so few initiatives actually deliver lasting impact? While funding flows into biotech and life sciences, many leaders overlook the complex strategies needed to bridge research and real-world application. Are you ready to discover the key to successful healthcare innovation and make informed decisions that truly drive change? In this episode, Shlomo Noy, a pioneer in biotech investment and former VP of R&D at Sheba Medical Center, breaks down the secrets behind impactful investments in healthcare. From reshaping the DNA of institutions to aligning incentives for breakthrough results, Shlomo reveals the strategies that fuel successful innovation on a global scale. 🎙️ What’s Inside: 1️⃣ The Art of Incentives: Discover how to balance researcher motivations with long-term institutional gains for innovation that sticks. 2️⃣ Israel's "Silicon Wadi" Secret: Learn how Israel transformed its natural limitations into a biotech powerhouse - and what other regions can learn from this approach. 3️⃣ Opportunities in China's Healthcare Market: Shlomo shares his insights on the untapped potential of China's rapidly growing healthcare sector, including strategic entry points for Western companies. 👤 About Shlomo Noy: With over 25 years of experience, Shlomo Noy has led R&D at one of the world’s top-ranked hospitals and spearheaded healthcare investments worldwide. His expertise in aligning financial, clinical, and technological insights offers a rare, multidimensional view on successful healthcare innovation. 💡 QUOTES: (00:08:14) "In life sciences, bridging finance with clinical insight isn’t optional; it’s essential." (00:29:39) "Transforming healthcare innovation requires reshaping the DNA of an entire organization." (00:41:02) "Our natural resource isn’t oil or gas - it’s the innovative minds of our people." (01:34:49) "China’s healthcare market is ready for innovation - and the opportunity is enormous." (02:12:54) "In the next 5-10 years, China's focus on women's health will redefine global markets." ⏰ Timestamps: (00:04:10) Shlomo Noy's Journey in Healthcare and Biotech Leadership (00:07:38) Multidisciplinary Teams: A Key to Biotech Investment Success (00:19:22) Protecting Researchers with In-House Tech Transfer Support (00:29:39) Transforming Healthcare: Changing the DNA of Innovation (00:38:36) Israel’s Silicon Wadi: The Biotech Innovation Boom (00:48:35) How Incentives Drive Institutional Tech Transfer Success (01:04:50) AI's Role in Drug Discovery and Patient Recruitment Challenges (01:20:02) China’s Healthcare Market: Uncovering Growth Opportunities (01:28:53) Clinical Trials in China: Scale and Efficiency Advantages (01:37:00) How Biotech Companies Can Navigate China’s Clinical Trial Landscape (01:53:03) Global Investment: Aligning Interests in Healthcare Innovation (02:17:13) Key Takeaways: Managing Innovation and China’s Healthcare Market If you’re ready to uncover the strategies behind impactful healthcare investments and explore new markets with confidence, this episode is packed with insights you won’t want to miss. Subscribe, comment, and share to help us bring more valuable content from leaders like Shlomo Noy. 👀 Stay Tuned: Watch the entire episode to learn how to harness innovation, incentivize success, and navigate global healthcare opportunities. Send us Fan Mail Support the show Join the Podcast Newsletter: Link Your Next Move: Link

Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.

Hosts and Guests

Nobody is credited on this episode yet.

Credit the people on this episode

Be the first to rate this episode

More episodes

All episodes
  1. Spark 20: Alex Dang | Everyone Agrees? Think Again. How Venture Capitalists Decide

    Nov 1, 202629 minAudio

    Invest in the wrong startup and you lose one times your money. Miss the next Google and you lose ten thousand times. Most boards are built to avoid the first mistake. Venture capitalists play by different rules. They...

    Credit the people on this episode

  2. EP 185: Ivy Nguyen | IQ, EQ and the Execution Quotient Investors Fund

    Oct 18, 20261 hr 4 minAudio

    The trait a Silicon Valley AI investor rewards most in a management team has a name almost nobody uses: XQ. IQ brings the idea and EQ reads the people across the table. The execution quotient shows in something as small...

    Credit the people on this episode

  3. EP 184: Ivy Nguyen | 10,000 AI Pitches and the One Test That Matters

    Oct 15, 202659 minAudio

    In 2017 another investor told Ivy Nguyen that artificial intelligence was too small a niche to dedicate a fund to. More than ten thousand AI pitches later, every pitch deck says AI. Single funding rounds have grown...

    Credit the people on this episode

  4. EP 183: Marie Schroeder | Send the Rough Deck, Not the Perfect One

    Sep 27, 20262 hr 5 minAudio

    A seed investor at Novo Holdings would rather read your rough idea than your finished pitch deck. Most founders spend a year building the deck, forming the team and waiting until the story holds together. By the time it...

    Credit the people on this episode

  5. #182 - How to Lead When You Don't Know Where You Are Going: 4 Lessons from Ben Horowitz (Part 2 of 2)

    Sep 8, 202657 minAudio

    What does it mean when the most respected adviser in Silicon Valley tells you that you are the best chief executive he works with, while your company is heading straight into a wall? Bill Campbell said exactly that to...

    Credit the people on this episode